Philips Reiterates FY2026 Outlook: Comparable Sales Growth 3%-4.5%, Adjusted EBITA Margin 13.5%-14.0%, Free Cash Flow EUR 1.5B-1.7B, Including US Tariff Refund Benefits

Outlook 

• Philips reiterates its full-year 2026 outlook: 
• Comparable sales growth: 3%-4.5% 
• Adjusted EBITA margin: 13.5%-14.0%, including a US tariff refund benefit of approximately 1% 
• Free cash flow: EUR 1.5-1.7 billion, including a net US tariff refund benefit of approximately EUR 200 million 

Within the context of an uncertain macro-environment, Philips' 2026 outlook includes currently known tariffs and assumes payment of the US Department of Justice settlement in the first quarter of 2027. The outlook excludes other ongoing Philips Respironics-related proceedings, including the investigation by the US State Attorneys General.